Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mohd Hazmi Mohamed
Analysis of the Association Between CFH Y402H Polymorphism and Response to Intravitreal Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Bosnian Journal of Basic Medical Sciences
Medicine
Related publications
Effect of ARMS2 Gene Polymorphism on Intravitreal Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
Genetics and Molecular Research
Medicine
Genetics
Molecular Biology
Association of CFH Y402H and LOC387715 A69S With Progression of Age-Related Macular Degeneration
JAMA - Journal of the American Medical Association
Medicine
Choroidal Blood Flow After the First Intravitreal Ranibizumab Injection in Neovascular Age-Related Macular Degeneration Patients
Acta Ophthalmologica
Medicine
Ophthalmology
Peripapillary Choroidal Thickness After Intravitreal Ranibizumab Injections in Eyes With Neovascular Age-Related Macular Degeneration
BMC Ophthalmology
Medicine
Ophthalmology
CFH Haplotypes Without the Y402H Coding Variant Show Strong Association With Susceptibility to Age-Related Macular Degeneration
Nature Genetics
Genetics
Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration
New England Journal of Medicine
Medicine
Macular Functional Changes in Patients With Neovascular Age-Related Macular Degeneration Receiving Ranibizumab Therapy (Lucentis)
BMC Geriatrics
Gerontology
Geriatrics
PSS10 Cost- Effectiveness of Ranibizumab in Patients With Neovascular Wet Age-Related Macular Degeneration (Namd) at the Mexican Social Security System (Imss)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ranibizumab Monotherapy in Neovascular Age-Related Macular Degeneration With Pigment Epithelial Detachment
Journal of Clinical & Experimental Ophthalmology
